Google Halts UK YouTube TV Measurement Service After Legal Action 
Apple Earnings Beat Expectations as iPhone Sales Surge to Four-Year High 
Pentagon and Anthropic Clash Over AI Safeguards in National Security Use 
Meta Stock Surges After Q4 2025 Earnings Beat and Strong Q1 2026 Revenue Outlook Despite Higher Capex 
Apple Forecasts Strong Revenue Growth as iPhone Demand Surges in China and India 
Panama Supreme Court Voids CK Hutchison Port Concessions, Raising Geopolitical and Trade Concerns 
Samsung Electronics Posts Record Q4 2025 Profit as AI Chip Demand Soars 
Apple Faces Margin Pressure as Memory Chip Prices Surge Amid AI Boom 
CSPC Pharma and AstraZeneca Forge Multibillion-Dollar Partnership to Develop Long-Acting Peptide Drugs 
Chinalco and Rio Tinto Acquire Controlling Stake in Brazil’s CBA for $903 Million 
Elon Musk’s SpaceX Explores Merger Options With Tesla or xAI, Reports Say 
Woodside Energy Flags Lower 2026 Production Outlook Despite Strong Q4 Revenue Beat 
Climate Adaptation at Home: How Irrigreen Makes Conservation Effortless 
Tesla Q4 Earnings Beat Expectations as Company Accelerates Shift Toward AI and Robotics 
The Maire - EuroChem Case: Three Lessons for Global Business 
First Abu Dhabi Bank Reports 22% Jump in Q4 Profit, Beats Market Expectations 
ALLEN, Texas, May 23, 2017 -- Atrion Corporation (Nasdaq:ATRI) today announced that its Board of Directors declared a quarterly cash dividend of $1.05 per share on the Company’s outstanding Common Stock. This dividend will be payable on June 30, 2017 to stockholders of record at the close of business on June 15, 2017.
Atrion Corporation develops and manufactures products primarily for medical applications. The Company’s website is www.atrioncorp.com.
Jeffery Strickland Vice President and Chief Financial Officer (972) 390-9800
